These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10475035)

  • 1. [Ex vivo and in vivo purging for PBSCT].
    Moriyama Y
    Rinsho Byori; 1999 May; Suppl 110():79-84. PubMed ID: 10475035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should we purge?
    Bensinger WI
    Bone Marrow Transplant; 1998 Jan; 21(2):113-5. PubMed ID: 9489625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo purging with NK-92 prior to autografting for chronic myelogenous leukemia.
    Maki G; Tam YK; Berkahn L; Klingemann HG
    Bone Marrow Transplant; 2003 Jun; 31(12):1119-25. PubMed ID: 12796791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex-vivo purging of hematopoietic progenitor cells.
    de Lima M; Shpall EJ
    Curr Hematol Rep; 2004 Jul; 3(4):257-64. PubMed ID: 15217555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is bone marrow purging proving to be of value?
    Gulati SC; Romero CE; Ciavarella D
    Oncology (Williston Park); 1994 Sep; 8(9):19-24; discussion 24, 29-32. PubMed ID: 7993723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purging of peripheral blood progenitor cell autografts and treatment of minimal residual disease.
    Brugger W; Scheding S; Bock T; Ziegler B; Kanz L
    Stem Cells; 1997; 15 Suppl 1():159-65. PubMed ID: 9368336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purging of peripheral blood stem cell grafts.
    Gee A
    Stem Cells; 1995 Dec; 13 Suppl 3():52-62. PubMed ID: 8747989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological purging of breast cancer cell lines using a replication-competent oncolytic virus in human stem cell autografts.
    Thirukkumaran CM; Luider JM; Stewart DA; Alain T; Russell JA; Auer IA; Forsyth P; Morris DG
    Bone Marrow Transplant; 2005 Jun; 35(11):1055-64. PubMed ID: 15821774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell purging ex vivo.
    Seiden MV; Anderson KC
    J Infus Chemother; 1996; 6(1):17-22. PubMed ID: 8748002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction.
    Atta J; Fauth F; Keyser M; Petershofen E; Weber C; Lippok G; Hoelzer D; Martin H
    Bone Marrow Transplant; 2000 Jan; 25(1):97-104. PubMed ID: 10654022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo expansion of bone marrow from breast cancer patients: reduction in tumor cell content through passive purging.
    Lundell BI; Vredenburgh JJ; Tyer C; DeSombre K; Smith AK
    Bone Marrow Transplant; 1998 Jul; 22(2):153-9. PubMed ID: 9707023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised comparison of two B-cell purging protocols for patients with B-cell non-Hodgkin lymphoma: in vivo purging with rituximab versus ex vivo purging with CliniMACS CD34 cell enrichment device.
    van Heeckeren WJ; Vollweiler J; Fu P; Cooper BW; Meyerson H; Lazarus HM; Simic A; Laughlin MJ; Gerson SL; Koç ON
    Br J Haematol; 2006 Jan; 132(1):42-55. PubMed ID: 16371019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell purging: an intriguing dilemma.
    Rizzoli V; Carlo-Stella C
    Exp Hematol; 1995 Apr; 23(4):296-302. PubMed ID: 7895779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developments in purging in autotransplantation.
    Freedman AS; Nadler LM
    Hematol Oncol Clin North Am; 1993 Jun; 7(3):687-715. PubMed ID: 8344886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient and nontoxic adenoviral purging method for autologous transplantation in breast cancer patients.
    Lillo R; Ramírez M; Alvarez A; Santos S; García-Castro J; Fernández de Velasco J; Avilés MJ; Gómez-Pineda A; Díez JL; Balas A; Vicario JL; Bueren JA; García-Sánchez F
    Cancer Res; 2002 Sep; 62(17):5013-8. PubMed ID: 12208755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
    De Rosa L; Lalle M; Pandolfi A; Ruscio C; Amodeo R
    Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo purging and relapse prevention following ASCT.
    Gisselbrecht C
    Bone Marrow Transplant; 2002 Feb; 29 Suppl 1():S5-9. PubMed ID: 11840154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
    Bierman PJ; Sweetenham JW; Loberiza FR; Taghipour G; Lazarus HM; Rizzo JD; Schmitz N; van Besien K; Vose JM; Horowitz M; Goldstone A;
    J Clin Oncol; 2003 Oct; 21(20):3744-53. PubMed ID: 12963703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of immunomagnetic selection in purging autologous peripheral blood progenitor cell of breast cancer patients].
    Han X; Shi Y; Zhang W
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):203-6. PubMed ID: 11953162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab in vivo purging is safe and effective in combination with CD34-positive selected autologous stem cell transplantation for salvage therapy in B-NHL.
    Flohr T; Hess G; Kolbe K; Gamm H; Nolte H; Stanislawski T; Huber C; Derigs HG
    Bone Marrow Transplant; 2002 May; 29(9):769-75. PubMed ID: 12040475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.